Article
New mutations in ADC-type β-lactamases from Acinetobacter spp. affect cefoxitin and ceftazidime hydrolysis.
The Journal of antimicrobial chemotherapy - 1 Sept 2014
Pérez Astrid, Pérez-Llarena Francisco José, García Patricia, Kerff Frédéric, Beceiro Alejandro, Galleni Moreno, Bou Germán
Abstract excerpt
OBJECTIVES: Two natural variants of ADC-type β-lactamases of Acinetobacter spp., ADC-1 and ADC-5, differ by nine mutations in their protein sequence. ADC-5 hydrolyses cefoxitin better than ADC-1 and the opposite is true for ceftazidime. We produced single and combined mutations in ADC-5 and chara...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
